Plaintiff's damages methodology was found mostly reliable, as the court rejected defendant's assertion that plaintiff could have mitigated its damages since the evidence showed that defendant would not have cooperated with those mitigation efforts or the success of those efforts was speculative at best.

Defendants moved for summary judgment in plaintiff's race-based New Jersey Law Against Discrimination action and its counterclaim for breach of contract.

Only Retaliation Claim Survives in FCA Qui Tam Action Over Partially Used Medications

Plaintiff moved to represent all colchicine purchasers of brand name and generic colchicine through a class action asserting a conspiracy to restrain trade and to monopolize and court found plaintiff did not make a threshold showing of plausibility since plaintiff relied on an expert opinion from an economist who assumed facts based on plaintiff's counsel's proffered assumptions. Motion denied.